High Vista Strategies LLC Rocket Pharmaceuticals, Inc. Transaction History

High Vista Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $383,600 - $801,898	-48,191 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $16,818 - $30,263	1,278 Added 2.72%	48,191 $764,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $134,327 - $224,836	6,242 Added 15.35%	46,913 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $610,012 - $1.09 Million	22,247 Added 120.75%	40,671 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $161,108 - $193,158	4,088 Added 28.52%	18,424 $816,000
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $443,411 - $674,325	-10,231 Reduced 41.65%	14,336 $636,000
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $168,342 - $430,393	7,225 Added 41.66%	24,567 $1.35 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $157,481 - $219,628	-7,682 Reduced 30.7%	17,342 $396,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $333,319 - $565,792	25,024 New	25,024 $524,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $884M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.